Treatment with BTZ alone for 28 days decreased the tumor to 3,235.0 ± 678.2 mm3, compared with 6,234.7 ± 2,113.5 mm3 for the controls (P < 0.005; Fig. 6B). The gene discussed is CASC3; the disease is neoplasm.